Join us for this game-style symposium on relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) and R/R follicular lymphoma (FL) with treatment consideration for bispecific antibodies designed to encourage the exchange of ideas between leaders in the field and attendees. During this engaging session, 3 expert faculty will present clinical data with real-world practical considerations using patient cases to highlight best practices for integrating novel therapies into clinical practice. Throughout the presentation the audience will have the opportunity to participate in a group competition with the winners announced at the end of the session. Lastly, the faculty will field questions from the audience during a Q&A segment, enhancing the potential to discuss impactful treatment options.